Koyfin Home > Directory > Health Care > Acadia Pharmaceutica > Enterprise Value

Acadia Pharmaceutica Enterprise Value Chart (ACAD)

Acadia Pharmaceutica annual/quarterly Enterprise Value from 2010 to 2020.
  • Acadia Pharmaceutica Enterprise Value for the quarter ending September 09, 2020 was $5,741m a -0.61% decrease of -35m year over year
  • Acadia Pharmaceutica Enterprise Value for the last 12 months ending September 09, 2020 was $5,741m a -0.61% decrease of -35m year over year
  • Acadia Pharmaceutica Annual Enterprise Value for 2020 was $5,741m a 0.14% increase of 8m from 2019
  • Acadia Pharmaceutica Annual Enterprise Value for 2020 was $5,733m a 4.35% increase of 249m from 2019
  • Acadia Pharmaceutica Annual Enterprise Value for 2020 was $5,483m a -5.33% decrease of -292m from 2019
Other Valuation Metrics:
  • Acadia Pharmaceutica Market Cap for the quarter ending March 03, 2018 was $2,802m a -21.48% decrease of -602m year over year
  • Acadia Pharmaceutica Price / Book for the quarter ending March 03, 2018 was 8.34 a 10.81% increase of 0.90 year over year
View Chart On Koyfin

Quarterly ACAD Enterprise Value Data

09/2020$5,741m
09/2020$5,733m
09/2020$5,483m
09/2020$5,775m
09/2020$5,858m
09/2020$5,914m
09/2020$6,088m
09/2020$5,825m
09/2020$5,577m
09/2020$5,512m

Annual ACAD Enterprise Value Data

2020$5,741m
2020$5,733m
2020$5,483m
2020$5,775m
2020$5,858m
2020$5,914m
2020$6,088m
2020$5,825m
2020$5,577m
2020$5,512m